---
figid: PMC3736525__ECAM2013-705121.004
figtitle: Lycopene inhibits theWnt/Beta-catenin pathway
organisms:
- Nicotiana tabacum
- Glycine max
- Solanum lycopersicum
- Diaporthe sclerotioides
- Allium sativum
- Citrus x paradisi
- Melia azedarach
- Carica papaya
- Citrullus lanatus subsp. vulgaris
- Prunus armeniaca
- Psidium guajava
- Serenoa repens
- Mus musculus
- Rattus norvegicus
- Cricetulus griseus
- Cricetus cricetus
- Homo sapiens
- Canis lupus familiaris
organisms_ner:
- Rattus norvegicus
- Canis lupus familiaris
- Cricetulus griseus
- Mus musculus
- Homo sapiens
- Solanum lycopersicum
- Danio rerio
pmcid: PMC3736525
filename: ECAM2013-705121.004.jpg
figlink: /pmc/articles/PMC3736525/figure/fig4/
number: F4
caption: Lycopene inhibits theWnt/β-catenin pathway. In the absence of Wnt, a multiprotein
  complex that includes axin, APC, and GSK3β destabilises β-catenin. β-catenin is
  phosphorylated by GSK3β and is subsequently degraded by the proteasome. Binding
  of Wnt to its cell surface receptors Fzd and Lrp 5/6 inhibits the phosphorylation
  of β-catenin by GSK3β, allowing β-catenin to accumulate within the cytosol. β-catenin
  then translocates into the nucleus, where it binds and activates LEF/TCF and induces
  gene expression. Lycopene increases the expression of E-cadherin, nm23-H1, and TIMP2,
  as well as the activity of GSK3β. Furthermore, it decreases the levels of MMPs 2,
  7, and 9, uPA, and β-catenin. Lycopene also induces its antimetastatic effects through
  the inactivation of transcription factors (NF-κB, AP-1, SP-1, and LEF/TCF).
papertitle: Multiple Molecular and Cellular Mechanisms of Action of Lycopene in Cancer
  Inhibition.
reftext: Cristina Trejo-Solís, et al. Evid Based Complement Alternat Med. 2013;2013:705121.
year: '2013'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9401706
figid_alias: PMC3736525__F4
figtype: Figure
redirect_from: /figures/PMC3736525__F4
ndex: aff6a9e5-df05-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3736525__ECAM2013-705121.004.html
  '@type': Dataset
  description: Lycopene inhibits theWnt/β-catenin pathway. In the absence of Wnt,
    a multiprotein complex that includes axin, APC, and GSK3β destabilises β-catenin.
    β-catenin is phosphorylated by GSK3β and is subsequently degraded by the proteasome.
    Binding of Wnt to its cell surface receptors Fzd and Lrp 5/6 inhibits the phosphorylation
    of β-catenin by GSK3β, allowing β-catenin to accumulate within the cytosol. β-catenin
    then translocates into the nucleus, where it binds and activates LEF/TCF and induces
    gene expression. Lycopene increases the expression of E-cadherin, nm23-H1, and
    TIMP2, as well as the activity of GSK3β. Furthermore, it decreases the levels
    of MMPs 2, 7, and 9, uPA, and β-catenin. Lycopene also induces its antimetastatic
    effects through the inactivation of transcription factors (NF-κB, AP-1, SP-1,
    and LEF/TCF).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Igbp1
  - Igf1
  - Wnt2
  - Igf1r
  - Apc
  - Akt1
  - Timp1
  - Timp2
  - Nfkb1
  - Rela
  - Ctnnb1
  - Sp1
  - Mmp9
  - Mmp2
  - Mmp7
  - Prap1
  - Serpine1
  - Ptpra
  - IGBP1
  - IGF1R
  - APC
  - TIMP2
  - CTNNB1
  - JUN
  - SP1
  - MMP9
  - MMP2
  - MMP7
  - SERPINE1
  - MVP
  - Jun
  - Plau
  - Serpine2
  - Lrp1
  - Mvp
  - Txlng
  - IGF1
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - PROC
  - AKT1
  - AKT2
  - AKT3
  - TIMP1
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - NME1
  - FOS
  - FOSB
  - JUNB
  - JUND
  - PSG1
  - DAND5
  - MMP1
  - MMP3
  - MMP8
  - MMP10
  - MMP11
  - MMP12
  - MMP13
  - MMP14
  - MMP15
  - MMP16
  - MMP17
  - MMP19
  - MMP20
  - MMP21
  - MMP23B
  - MMP24
  - MMP25
  - MMP26
  - MMP27
  - MMP28
  - PLAU
  - PRAP1
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - HNF4A
  - RPSA
  - LRP1
  - PTPRA
  - CDH1
  - CDH10
  - CDH11
  - CDH12
  - CDH13
  - CDH15
  - CDH16
  - CDH17
  - CDH18
  - CDH19
  - CDH2
  - CDH20
  - CDH22
  - CDH24
  - CDH3
  - CDH4
  - CDH5
  - CDH6
  - CDH7
  - CDH8
  - CDH9
  - MADS-MC
  - actin
  - LRP
  - igbp1
  - igfn1.2
  - apc
  - timp2a
  - ctnnb1
  - sp1
  - mmp9
  - mmp2
  - serpine1
  - elk4
  - cby1
  - Cancer
---
